Search research articles
Contact Us
Filters
Showing results (281-290 of 393) with videos related to
Page
of 40
Sort By:
Neuroimage. Clinical
|
February 26, 2014
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks
V Popescu, N C G Ran, F Barkhof, et al.
Lancet (London, England)
|
April 1, 1978
Fetal wastage as a result of an alpha-fetoprotein screening programme
Y B Gordon, J G Grudzinskas, M J Kitau, et al.
British Journal of Obstetrics and Gynaecology
|
October 1, 1977
Circulating levels of pregnancy-specific beta1-glycoprotein in early pregnancy
J G Grudzinskas, E A Lenton, Y B Gordon, et al.
British Journal of Obstetrics and Gynaecology
|
April 1, 1981
Measurement of placental protein 5, placental lactogen and pregnancy-specific beta 1 glycoprotein in mid-trimester as a predictor of outcome of pregnancy
H T Salem, J N Lee, M Seppälä, et al.
Cancer
|
July 1, 1991
Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2
P A van Dam, D G Lowe, J V Watson, et al.
Brain : a Journal of Neurology
|
February 15, 2002
Brain atrophy in clinically early relapsing-remitting multiple sclerosis
D T Chard, C M Griffin, G J M Parker, et al.
Neurology
|
January 15, 2003
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial
S M Leary, D H Miller, V L Stevenson, et al.
Neuroimage
|
April 28, 2004
Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis
Jaume Sastre-Garriga, Gordon T Ingle, Declan T Chard, et al.
Prenatal Diagnosis
|
August 1, 1995
Urinary multiple marker screening for Down's syndrome
H S Cuckle, R K Iles, I K Sehmi, et al.
Prenatal Diagnosis
|
March 1, 1994
Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks
M C Macintosh, R Iles, B Teisner, et al.
Page
of 40
Search research articles
Search
Showing results (281-290 of 393) with videos related to
Sort By:
Page
of 40
Neuroimage. Clinical
|
February 26, 2014
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks
V Popescu, N C G Ran, F Barkhof, et al.
Lancet (London, England)
|
April 1, 1978
Fetal wastage as a result of an alpha-fetoprotein screening programme
Y B Gordon, J G Grudzinskas, M J Kitau, et al.
British Journal of Obstetrics and Gynaecology
|
October 1, 1977
Circulating levels of pregnancy-specific beta1-glycoprotein in early pregnancy
J G Grudzinskas, E A Lenton, Y B Gordon, et al.
British Journal of Obstetrics and Gynaecology
|
April 1, 1981
Measurement of placental protein 5, placental lactogen and pregnancy-specific beta 1 glycoprotein in mid-trimester as a predictor of outcome of pregnancy
H T Salem, J N Lee, M Seppälä, et al.
Cancer
|
July 1, 1991
Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2
P A van Dam, D G Lowe, J V Watson, et al.
Brain : a Journal of Neurology
|
February 15, 2002
Brain atrophy in clinically early relapsing-remitting multiple sclerosis
D T Chard, C M Griffin, G J M Parker, et al.
Neurology
|
January 15, 2003
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial
S M Leary, D H Miller, V L Stevenson, et al.
Neuroimage
|
April 28, 2004
Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis
Jaume Sastre-Garriga, Gordon T Ingle, Declan T Chard, et al.
Prenatal Diagnosis
|
August 1, 1995
Urinary multiple marker screening for Down's syndrome
H S Cuckle, R K Iles, I K Sehmi, et al.
Prenatal Diagnosis
|
March 1, 1994
Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks
M C Macintosh, R Iles, B Teisner, et al.
Page
of 40